169 related articles for article (PubMed ID: 16388410)
1. Probing beta relaxation in pharmaceutically relevant glasses by using DSC.
Vyazovkin S; Dranca I
Pharm Res; 2006 Feb; 23(2):422-8. PubMed ID: 16388410
[TBL] [Abstract][Full Text] [Related]
2. Coupling between chemical reactivity and structural relaxation in pharmaceutical glasses.
Shamblin SL; Hancock BC; Pikal MJ
Pharm Res; 2006 Oct; 23(10):2254-68. PubMed ID: 16941232
[TBL] [Abstract][Full Text] [Related]
3. Water vapor absorption into amorphous hydrophobic drug/poly(vinylpyrrolidone) dispersions.
Crowley KJ; Zografi G
J Pharm Sci; 2002 Oct; 91(10):2150-65. PubMed ID: 12226842
[TBL] [Abstract][Full Text] [Related]
4. Physical stability and relaxation of amorphous indomethacin.
Vyazovkin S; Dranca I
J Phys Chem B; 2005 Oct; 109(39):18637-44. PubMed ID: 16853398
[TBL] [Abstract][Full Text] [Related]
5. Molecular mobility-based estimation of the crystallization rates of amorphous nifedipine and phenobarbital in poly(vinylpyrrolidone) solid dispersions.
Aso Y; Yoshioka S; Kojima S
J Pharm Sci; 2004 Feb; 93(2):384-91. PubMed ID: 14705195
[TBL] [Abstract][Full Text] [Related]
6. Glass transition and enthalpy relaxation of amorphous lactose glass.
Haque MK; Kawai K; Suzuki T
Carbohydr Res; 2006 Aug; 341(11):1884-9. PubMed ID: 16709405
[TBL] [Abstract][Full Text] [Related]
7. A mechanistic investigation of an amorphous pharmaceutical and its solid dispersions, part I: a comparative analysis by thermally stimulated depolarization current and differential scanning calorimetry.
Shmeis RA; Wang Z; Krill SL
Pharm Res; 2004 Nov; 21(11):2025-30. PubMed ID: 15587924
[TBL] [Abstract][Full Text] [Related]
8. Dielectric analysis in the characterization of amorphous pharmaceutical solids. 1. Molecular mobility in poly(vinylpyrrolidone)-water systems in the glassy state.
Duddu SP; Sokoloski TD
J Pharm Sci; 1995 Jun; 84(6):773-6. PubMed ID: 7562421
[TBL] [Abstract][Full Text] [Related]
9. Co-relationship of physical stability of amorphous dispersions with enthalpy relaxation.
Bansal SS; Kaushal AM; Bansal AK
Pharmazie; 2008 Nov; 63(11):812-4. PubMed ID: 19069241
[TBL] [Abstract][Full Text] [Related]
10. Investigation of preparation methods on surface/bulk structural relaxation and glass fragility of amorphous solid dispersions.
Ke P; Hasegawa S; Al-Obaidi H; Buckton G
Int J Pharm; 2012 Jan; 422(1-2):170-8. PubMed ID: 22079715
[TBL] [Abstract][Full Text] [Related]
11. Investigation of physical properties and stability of indomethacin-cimetidine and naproxen-cimetidine co-amorphous systems prepared by quench cooling, coprecipitation and ball milling.
Lim AW; Löbmann K; Grohganz H; Rades T; Chieng N
J Pharm Pharmacol; 2016 Jan; 68(1):36-45. PubMed ID: 26663364
[TBL] [Abstract][Full Text] [Related]
12. The effect of annealing on the stability of amorphous solids: chemical stability of freeze-dried moxalactam.
Abdul-Fattah AM; Dellerman KM; Bogner RH; Pikal MJ
J Pharm Sci; 2007 May; 96(5):1237-50. PubMed ID: 17455341
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the impact of annealing on global molecular mobility in glasses: optimization for stabilization of amorphous pharmaceuticals.
Luthra SA; Hodge IM; Pikal MJ
J Pharm Sci; 2008 Sep; 97(9):3865-82. PubMed ID: 18200533
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of glassy-state dynamics from the width of the glass transition: results from theoretical simulation of differential scanning calorimetry and comparisons with experiment.
Pikal MJ; Chang LL; Tang XC
J Pharm Sci; 2004 Apr; 93(4):981-94. PubMed ID: 14999734
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the molecular distribution of drugs in glassy solid dispersions at the nano-meter scale, using differential scanning calorimetry and gravimetric water vapour sorption techniques.
van Drooge DJ; Hinrichs WL; Visser MR; Frijlink HW
Int J Pharm; 2006 Mar; 310(1-2):220-9. PubMed ID: 16427226
[TBL] [Abstract][Full Text] [Related]
16. Enthalpy relaxation in binary amorphous mixtures containing sucrose.
Shamblin SL; Zografi G
Pharm Res; 1998 Dec; 15(12):1828-34. PubMed ID: 9892465
[TBL] [Abstract][Full Text] [Related]
17. A molecular dynamics simulation of reactant mobility in an amorphous formulation of a peptide in poly(vinylpyrrolidone).
Xiang TX; Anderson BD
J Pharm Sci; 2004 Apr; 93(4):855-76. PubMed ID: 14999724
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the physical stability of amorphous felodipine and nifedipine systems.
Marsac PJ; Konno H; Taylor LS
Pharm Res; 2006 Oct; 23(10):2306-16. PubMed ID: 16927182
[TBL] [Abstract][Full Text] [Related]
19. Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures.
Hancock BC; Shamblin SL; Zografi G
Pharm Res; 1995 Jun; 12(6):799-806. PubMed ID: 7667182
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of indomethacin crystallization in poly(vinylpyrrolidone) coprecipitates.
Yoshioka M; Hancock BC; Zografi G
J Pharm Sci; 1995 Aug; 84(8):983-6. PubMed ID: 7500284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
